NEPH · Nephros Inc · Metrics
$2.79
-0.30 (-9.71%)
At close · Nov 6
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$32.61M
Shares
10.87M
Volume · Nov 6
104.03K
Avg daily vol (3M)
39.66K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
NEPH metrics
84 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$2.79
Market cap
$32.61M
Price action
23 metricsPrice change (1W)
-5.5%
Price change (30D)
-3.4%
Price change (3M)
-13.9%
Price change (6M)
-4.3%
Price change (YTD)
-36.7%
Price change (1Y)
-45.7%
Trailing year
Price change (5Y)
-60.8%
52-week high
$5.79
52-week low
$2.78
Change from 52-week high
-46.6%
Change from 52-week low
+11.2%
Annualized volatility
84.4%
Annualized volatility (3M)
78.5%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
0.9
RSI (14D)
35.5
Price vs SMA 50
-19.2%
Price vs SMA 200
-15.1%
Avg volume (3M)
38,342
Relative volume
0.8
Average dollar volume
$144,200
Company
3 metricsSector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
10.87M
Valuation
12 metricsP / E (TTM)
17.2
Trailing earnings · reciprocal yield 5.8%
PEG ratio
0.3
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.5×
reciprocal yield 66.2%
P / book
2.6
reciprocal yield 38.5%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
5.9%
Historical valuation
8 metricsP / E historical average (3Y)
45.4×
reciprocal yield 2.2%
P / E historical average (5Y)
45.4×
reciprocal yield 2.2%
EV / revenue historical average (3Y)
3.6×
reciprocal yield 27.5%
EV / revenue historical average (5Y)
4.4×
reciprocal yield 22.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-11-05
Profitability
9 metricsGross margin
60.5%
Operating margin
8.5%
Trailing 12 months
Net margin
8.9%
Gross profit (TTM)
$13.07M
Operating profit (TTM)
$1.83M
Net income (TTM)
$1.91M
Trailing 12 months
Diluted EPS (TTM)
$0.18
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+18.0%
Year over year
Net income growth YoY
+51.9%
Revenue (TTM)
$21.58M
Trailing 12 months
EPS growth YoY
+66.7%
Shares change YoY
+1.5%
Year over year · more shares
Revenue CAGR (3Y)
+23.5%
Revenue CAGR (5Y)
+17.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
15.2%
Return on assets
12.5%
Debt / equity
—
Current ratio
5.5
EBITDA (TTM)
$1.95M
Free cash flow (TTM)
—
Quick ratio
3.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$4.55M
Total assets
$15.30M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$955,000
Capital expenditures (TTM)
—
R&D (TTM)
$1.44M
SG&A (TTM)
$9.68M
Stock compensation (TTM)
$260,000
R&D / revenue
6.7%
Stock compensation / revenue
1.2%
Ownership (13F)
9 metrics13F filers
33
13F filer change QoQ
+6
Institutional ownership
48.9%
Conviction holders (share of 13F filers)
3.0%
Crowding (high-turnover and private-fund holders)
37.0%
Private-fund adviser ownership
37.0%
Active holders' share change QoQ
-2.0%
Holder tenure
20.9
Price vs estimated holder cost
-2.9%
Ownership (registered funds)
1 metricsIndex-fund ownership
2.5%
Short interest
3 metricsShort interest
0.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
24 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—